Home » Topics » BioWorld Science

BioWorld Science
RSS

Rat model mimics the features of cerebral small vessel disease

Nov. 16, 2021

BAY-56-6544 improves vasomotor function in accelerated-aging model

Nov. 16, 2021

CPI-381: a first-in-class TREX1 inhibitor with antitumor activity in preclinical models

Nov. 16, 2021

Enhancing endothelial cell S1PR1 signaling attenuates arthritis in vivo

Nov. 16, 2021

BioArctic developing antibody treatments targeting TDP-43 for ALS

Nov. 16, 2021

C4X Discovery Holdings patents NFE2L2 activators

Nov. 16, 2021

Plexxikon identifies new CD73 inhibitors

Nov. 16, 2021

Taiho Pharmaceutical presents new GTPase KRAS mutant inhibitors

Nov. 16, 2021

Roche discloses GABA-A receptor PAMs

Nov. 16, 2021

Sumitomo Dainippon Pharma patents new compounds for epilepsy

Nov. 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...